QA: Anebulo Pharmaceuticals Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001815974_2025_Anebulo_Pharmaceuticals_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001815974, Anebulo Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 3,507,990
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 565,124
4 LiabilitiesCurrent 156,426
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 104,157
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 3,663,690
9 ResearchAndDevelopmentExpense 3,832,262
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 87,898
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 4,073,114
1 Liabilities 260,583
2 Expenses 7,495,952
3 Revenues 0
4 StockholdersEquity 3,812,531
5 NetIncome -7,408,054
6 ComprehensiveNetIncome -7,408,054
7 BaseVar 5,958,774
8 EconomicCapitalRatiobeforeLimitedLiability 0.417
9 EconomicCapitalRatio 1.81

Edgar->Model Mapping

Feature Distribution

Change over Time